Ticker
AIMCompany Name
AIM IMMUNOTECH INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -14.93M | $ -19.67 | 1 | 759.29K |
3/31/2025 | $ -13.89M | $ -19.75 | 1 | 703.3K |
12/31/2024 | $ -16.18M | $ -28.89 | 1 | 560.17K |
9/30/2024 | $ -23.1M | $ -40.05 | 1 | 576.77K |
6/30/2024 | $ -27.28M | $ -51.62 | 1 | 528.38K |
3/31/2024 | $ -30.58M | $ -61.82 | 1 | 494.58K |
12/31/2023 | $ -28.44M | $ -58.53 | 1 | 485.85K |
9/30/2023 | $ -20.27M | $ -41.69 | 1 | 486.35K |
6/30/2023 | $ -19.02M | $ -39.29 | 1 | 484.11K |
3/31/2023 | $ -19.01M | $ -39.28 | 1 | 484K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for AIM IMMUNOTECH INC is calculated as follows: EBITDA [ $ -10.44M ] / (Shares WA [ 389.07K ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -26.83 ]
Minimum
Mar 31, 2024
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.78K |
---|---|
min | $ -11.29 |
max | $ 14.03 |
average | $ 2.03 |
median | $ 1 |
std | $ 4.28 |